#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13338	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2117	625.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1442	1442	C	797	C,T	750,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13338	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2117	625.6	0	HET	.	.	.	C1450T	.	1450	1450	C	1708	1708	C	726	C,T	406,278	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13338	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2117	625.6	0	HET	.	.	.	G1158A	.	1158	1158	G	1416	1416	G	770	G,A	626,95	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24202	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3415	704.2	0	.	n	.	0	T695C	SNP	695	695	T	938	938	C	710	C,T	375,287	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24202	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3415	704.2	0	.	n	.	0	G1337A	SNP	1337	1337	G	1580	1580	A	818	A,G	772,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24202	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3415	704.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2214	2214	C	824	C,T	774,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24202	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3415	704.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2288	2288	A	772	A	734	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24202	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3415	704.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	2840	2840	C	686	C,T	338,313	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	24202	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3415	704.2	0	HET	.	.	.	G2872A	.	2872	2872	G	3115	3115	G	678	G,A	489,150	.	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	155	1752	folP	852	852	100.0	folP.l15.c4.ctg.1	1486	117.3	1	SNP	p	R228S	1	.	.	682	684	AGC	953	955	AGC	203;204;204	A;G;C	192;192;192	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	155	1752	folP	852	852	100.0	folP.l15.c4.ctg.1	1486	117.3	0	HET	.	.	.	A694G	.	694	694	A	965	965	A	191	A,G	103,75	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	155	4474	gyrA	2751	2751	99.96	gyrA.l6.c30.ctg.1	3347	133.2	1	SNP	p	S91F	0	.	.	271	273	TCC	539	541	TCC	154;152;155	T;C;C	149;145;147	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	155	4474	gyrA	2751	2751	99.96	gyrA.l6.c30.ctg.1	3347	133.2	1	SNP	p	D95N	0	.	.	283	285	GAC	551	553	GAC	158;157;158	G;A;C	152;147;151	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	155	4474	gyrA	2751	2751	99.96	gyrA.l6.c30.ctg.1	3347	133.2	1	SNP	p	D95G	0	.	.	283	285	GAC	551	553	GAC	158;157;158	G;A;C	152;147;151	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	155	4474	gyrA	2751	2751	99.96	gyrA.l6.c30.ctg.1	3347	133.2	0	HET	.	.	.	G1032T	.	1032	1032	G	1300	1300	G	155	G,T	79,67	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	155	4474	gyrA	2751	2751	99.96	gyrA.l6.c30.ctg.1	3347	133.2	0	HET	.	.	.	T927G	.	927	927	T	1195	1195	T	141	T,G	73,57	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	155	4474	gyrA	2751	2751	99.96	gyrA.l6.c30.ctg.1	3347	133.2	0	HET	.	.	.	A882G	.	882	882	A	1150	1150	A	141	A,G	71,68	.	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	155	1410	mtrR	633	633	100.0	mtrR.l6.c17.ctg.1	1116	124.2	1	SNP	p	G45D	1	.	.	133	135	GAC	386	388	GAC	173;172;179	G;A,G;C	163;93,68;169	mtrR.WHO_W_01449:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	155	1410	mtrR	633	633	100.0	mtrR.l6.c17.ctg.1	1116	124.2	0	HET	.	.	.	A360G,C	.	360	360	A	613	613	A	162	A,G,C	82,63,1	.	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	155	1410	mtrR	633	633	100.0	mtrR.l6.c17.ctg.1	1116	124.2	0	HET	.	.	.	G115A	.	115	115	G	368	368	G	181	G,A	101,71	.	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	155	1410	mtrR	633	633	100.0	mtrR.l6.c17.ctg.1	1116	124.2	0	HET	.	.	.	C87G	.	87	87	C	340	340	C	177	C,G	103,63	.	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	155	1410	mtrR	633	633	100.0	mtrR.l6.c17.ctg.1	1116	124.2	0	HET	.	.	.	G345A	.	345	345	G	598	598	G	158	G,A	85,59	.	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	155	1410	mtrR	633	633	100.0	mtrR.l6.c17.ctg.1	1116	124.2	0	HET	.	.	.	C90T	.	90	90	C	343	343	C	173	C,T	103,62	.	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	155	1410	mtrR	633	633	100.0	mtrR.l6.c17.ctg.1	1116	124.2	0	HET	.	.	.	T354C	.	354	354	T	607	607	T	157	T,C	85,57	.	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	155	1410	mtrR	633	633	100.0	mtrR.l6.c17.ctg.1	1116	124.2	0	HET	.	.	.	G131A	.	131	131	G	384	384	G	172	G,A	96,69	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	800	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	923	86.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	667	4788	parC	2304	2304	99.87	parC.l6.c17.ctg.1	2864	166.2	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1429	1431	ATC	174;177;178	A,G;T;C	83,84;169;170	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	667	4788	parC	2304	2304	99.87	parC.l6.c17.ctg.1	2864	166.2	1	SNP	p	D86N	0	.	.	256	258	GAC	535	537	GAC	192;193;192	G,A;A;C	182,1;180;182	parC.WHO_G_00206c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	667	4788	parC	2304	2304	99.87	parC.l6.c17.ctg.1	2864	166.2	1	SNP	p	S87I	0	.	.	259	261	AGT	538	540	AGT	190;191;193	A;G,T;T	178;181,1;178	parC.WHO_G_00206c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	667	4788	parC	2304	2304	99.87	parC.l6.c17.ctg.1	2864	166.2	1	SNP	p	S87R	0	.	.	259	261	AGT	538	540	AGT	190;191;193	A;G,T;T	178;181,1;178	parC.WHO_G_00206c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	667	4788	parC	2304	2304	99.87	parC.l6.c17.ctg.1	2864	166.2	1	SNP	p	S87W	0	.	.	259	261	AGT	538	540	AGT	190;191;193	A;G,T;T	178;181,1;178	parC.WHO_G_00206c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	667	4788	parC	2304	2304	99.87	parC.l6.c17.ctg.1	2864	166.2	1	SNP	p	S88P	0	.	.	262	264	TCC	541	543	TCC	192;194;193	T;C;C,A	177;180;179,1	parC.WHO_G_00206c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	667	4788	parC	2304	2304	99.87	parC.l6.c17.ctg.1	2864	166.2	0	HET	.	.	.	T876C,G	.	876	876	T	1155	1155	T	186	T,C,G	97,80,1	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	667	4788	parC	2304	2304	99.87	parC.l6.c17.ctg.1	2864	166.2	0	HET	.	.	.	A1326G	.	1326	1326	A	1605	1605	A	181	A,G	87,80	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	667	4788	parC	2304	2304	99.87	parC.l6.c17.ctg.1	2864	166.2	0	HET	.	.	.	A879G	.	879	879	A	1158	1158	A	187	A,G	102,81	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	667	4788	parC	2304	2304	99.87	parC.l6.c17.ctg.1	2864	166.2	0	HET	.	.	.	T1431C,A	.	1431	1431	T	1710	1710	T	193	T,C,A	89,88,1	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	667	4788	parC	2304	2304	99.87	parC.l6.c17.ctg.1	2864	166.2	0	HET	.	.	.	T312C	.	312	312	T	591	591	T	182	T,C	87,81	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	667	4788	parC	2304	2304	99.87	parC.l6.c17.ctg.1	2864	166.2	0	HET	.	.	.	T1304C	.	1304	1304	T	1583	1583	T	170	T,C	89,68	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	667	4788	parC	2304	2304	99.87	parC.l6.c17.ctg.1	2864	166.2	0	HET	.	.	.	G1305A	.	1305	1305	G	1584	1584	G	170	G,A	93,67	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	667	4788	parC	2304	2304	99.87	parC.l6.c17.ctg.1	2864	166.2	0	HET	.	.	.	T1435C	.	1435	1435	T	1714	1714	T	193	T,C	90,88	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	667	4788	parC	2304	2304	99.87	parC.l6.c17.ctg.1	2864	166.2	0	HET	.	.	.	A1786G,T	.	1786	1786	A	2065	2065	A	181	A,G,T	87,83,1	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	667	4788	parC	2304	2304	99.87	parC.l6.c17.ctg.1	2864	166.2	0	HET	.	.	.	G990C	.	990	990	G	1269	1269	G	176	G,C	88,78	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	667	4788	parC	2304	2304	99.87	parC.l6.c17.ctg.1	2864	166.2	0	HET	.	.	.	C903T	.	903	903	C	1182	1182	C	188	C,T	103,78	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	155	3602	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2673	134.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1500	1502	GGC	205;204;203	G;G;C	191;189;186	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	155	3602	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2673	134.2	0	HET	.	.	.	T930C	.	930	930	T	1202	1202	T	163	T,C	79,74	.	.
penA.15.001	penA.15.001	1	1	667	3356	penA	1746	1746	99.83	penA.l15.c30.ctg.1	2271	146.0	0	.	p	.	0	D346_T347insT	INS	1036	1036	G	1360	1360	A	114	A	103	.	.
penA.15.001	penA.15.001	1	1	667	3356	penA	1746	1746	99.83	penA.l15.c30.ctg.1	2271	146.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1254	1256	GCA	178;179;178	G;C,A;A	169;169,1;170	penA.15.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.001	penA.15.001	1	1	667	3356	penA	1746	1746	99.83	penA.l15.c30.ctg.1	2271	146.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1257	1259	ATC	181;183;181	A;T;C	171;174;171	penA.15.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.001	penA.15.001	1	1	667	3356	penA	1746	1746	99.83	penA.l15.c30.ctg.1	2271	146.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1269	1271	GTG	198;196;194	G;T;G	188;184;183	penA.15.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.001	penA.15.001	1	1	667	3356	penA	1746	1746	99.83	penA.l15.c30.ctg.1	2271	146.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1269	1271	GTG	198;196;194	G;T;G	188;184;183	penA.15.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.001	penA.15.001	1	1	667	3356	penA	1746	1746	99.83	penA.l15.c30.ctg.1	2271	146.0	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1773	1775	ACC	163;164;167	A;C;C	145;151;153	penA.15.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.001	penA.15.001	1	1	667	3356	penA	1746	1746	99.83	penA.l15.c30.ctg.1	2271	146.0	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1827	1829	GCG	153;151;148	G;C;G	129;113;122	penA.15.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.001	penA.15.001	1	1	667	3356	penA	1746	1746	99.83	penA.l15.c30.ctg.1	2271	146.0	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1827	1829	GCG	153;151;148	G;C;G	129;113;122	penA.15.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.001	penA.15.001	1	1	667	3356	penA	1746	1746	99.83	penA.l15.c30.ctg.1	2271	146.0	1	SNP	p	G542S	0	.	.	1624	1626	GGC	1950	1952	GGC	159;160;159	G;G;C	144;143;143	penA.15.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.001	penA.15.001	1	1	667	3356	penA	1746	1746	99.83	penA.l15.c30.ctg.1	2271	146.0	1	SNP	p	G545S	0	.	.	1633	1635	GGC	1959	1961	GGC	146;145;144	G;G,T;C	129;127,1;130	penA.15.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.001	penA.15.001	1	1	667	3356	penA	1746	1746	99.83	penA.l15.c30.ctg.1	2271	146.0	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1977	1979	CCG	128;128;125	C,G;C;G	103,3;105;100	penA.15.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.15.001	penA.15.001	1	1	667	3356	penA	1746	1746	99.83	penA.l15.c30.ctg.1	2271	146.0	0	HET	.	.	.	G1596C	.	1596	1596	G	1922	1922	G	170	G,C	81,75	.	.
penA.15.001	penA.15.001	1	1	667	3356	penA	1746	1746	99.83	penA.l15.c30.ctg.1	2271	146.0	0	HET	.	.	.	A1599T,C	.	1599	1599	A	1925	1925	A	172	A,T,C	83,72,1	.	.
penA.15.001	penA.15.001	1	1	667	3356	penA	1746	1746	99.83	penA.l15.c30.ctg.1	2271	146.0	0	HET	.	.	.	G1509A	.	1509	1509	G	1835	1835	G	122	G,A	51,51	.	.
penA.15.001	penA.15.001	1	1	667	3356	penA	1746	1746	99.83	penA.l15.c30.ctg.1	2271	146.0	0	HET	.	.	.	T1510C	.	1510	1510	T	1836	1836	T	121	T,C	54,46	.	.
penA.15.001	penA.15.001	1	1	667	3356	penA	1746	1746	99.83	penA.l15.c30.ctg.1	2271	146.0	0	HET	.	.	.	G1034GCGACGA,GCGA	.	1034	1034	G	1357	1357	G	186	GCGACGA,GCGA	100,70	.	.
penA.15.001	penA.15.001	1	1	667	3356	penA	1746	1746	99.83	penA.l15.c30.ctg.1	2271	146.0	0	HET	.	.	.	C1512G	.	1512	1512	C	1838	1838	C	123	C,G	57,47	.	.
penA.15.001	penA.15.001	1	1	667	3356	penA	1746	1746	99.83	penA.l15.c30.ctg.1	2271	146.0	0	HET	.	.	.	C1529T	.	1529	1529	C	1855	1855	C	136	C,T	71,55	.	.
penA.15.001	penA.15.001	1	1	667	3356	penA	1746	1746	99.83	penA.l15.c30.ctg.1	2271	146.0	0	HET	.	.	.	C1547G	.	1547	1547	C	1873	1873	C	162	C,G	82,75	.	.
penA.15.001	penA.15.001	1	1	667	3356	penA	1746	1746	99.83	penA.l15.c30.ctg.1	2271	146.0	0	HET	.	.	.	C1518T	.	1518	1518	C	1844	1844	C	133	C,T	63,55	.	.
penA.15.001	penA.15.001	1	1	667	3356	penA	1746	1746	99.83	penA.l15.c30.ctg.1	2271	146.0	0	HET	.	.	.	C1551G	.	1551	1551	C	1877	1877	C	161	C,G	79,78	.	.
penA.15.001	penA.15.001	1	1	667	3356	penA	1746	1746	99.83	penA.l15.c30.ctg.1	2271	146.0	0	HET	.	.	.	G1521C	.	1521	1521	G	1847	1847	G	135	G,C	69,54	.	.
penA.15.001	penA.15.001	1	1	667	3356	penA	1746	1746	99.83	penA.l15.c30.ctg.1	2271	146.0	0	HET	.	.	.	C1713A	.	1713	1713	C	2039	2039	C	142	C,A	69,65	.	.
penA.15.001	penA.15.001	1	1	667	3356	penA	1746	1746	99.83	penA.l15.c30.ctg.1	2271	146.0	0	HET	.	.	.	T1524C,G	.	1524	1524	T	1850	1850	T	136	T,C,G	67,56,1	.	.
penA.15.001	penA.15.001	1	1	667	3356	penA	1746	1746	99.83	penA.l15.c30.ctg.1	2271	146.0	0	HET	.	.	.	T1269C	.	1269	1269	T	1595	1595	T	154	T,C	65,83	.	.
penA.15.001	penA.15.001	1	1	667	3356	penA	1746	1746	99.83	penA.l15.c30.ctg.1	2271	146.0	0	HET	.	.	.	T1719C	.	1719	1719	T	2045	2045	T	137	T,C	63,64	.	.
penA.15.001	penA.15.001	1	1	667	3356	penA	1746	1746	99.83	penA.l15.c30.ctg.1	2271	146.0	0	HET	.	.	.	A1621C	.	1621	1621	A	1947	1947	A	152	A,C	75,66	.	.
penA.15.001	penA.15.001	1	1	667	3356	penA	1746	1746	99.83	penA.l15.c30.ctg.1	2271	146.0	0	HET	.	.	.	C1497T,G	.	1497	1497	C	1823	1823	C	146	C,T,G	49,56,1	.	.
penA.15.001	penA.15.001	1	1	667	3356	penA	1746	1746	99.83	penA.l15.c30.ctg.1	2271	146.0	0	HET	.	.	.	C1530G	.	1530	1530	C	1856	1856	C	137	C,G	74,56	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5156	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3171	162.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	659	1972	porA	1146	1146	99.83	porA.l15.c17.ctg.1	1748	111.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	593	593	C	125	C	120	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	322	porB1a	984	309	91.05	porB1a.l15.c4.ctg.2	519	11.5	0	.	p	.	0	H217N	NONSYN	649	651	CAT	235	237	AAT	5;6;6	A;A;T	5;6;6	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	322	porB1a	984	309	91.05	porB1a.l15.c4.ctg.2	519	11.5	0	.	p	.	0	D218N	NONSYN	652	654	GAT	238	240	AAT	6;6;6	A;A;T	6;6;6	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	322	porB1a	984	309	91.05	porB1a.l15.c4.ctg.2	519	11.5	0	.	p	.	0	A222V	NONSYN	664	666	GCT	250	252	GTT	7;7;7	G;T;T	7;7;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	322	porB1a	984	309	91.05	porB1a.l15.c4.ctg.2	519	11.5	0	.	p	.	0	V226A	NONSYN	676	678	GTA	262	264	GCA	6;6;6	G;C;A	6;6;6	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	322	porB1a	984	309	91.05	porB1a.l15.c4.ctg.2	519	11.5	0	.	p	.	0	.	MULTIPLE	700	702	ACT	285	287	GTA	6;6;6	G,C;T;A	5,1;6;6	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	322	porB1a	984	309	91.05	porB1a.l15.c4.ctg.2	519	11.5	0	.	p	.	0	D238fs	FSHIFT	712	712	G	297	297	G	8	G	8	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2402	porB1b	1035	269	97.77	porB1b.l15.c30.ctg.1	384	159.5	0	.	p	.	0	A268V	NONSYN	802	804	GCG	36	38	GTG	90;93;95	G;T,C;G	42;22,27;50	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2402	porB1b	1035	269	97.77	porB1b.l15.c30.ctg.1	384	159.5	0	.	p	.	0	L275V	NONSYN	823	825	TTA	57	59	GTA	111;112;112	G;T;A	76;78;78	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2402	porB1b	1035	269	97.77	porB1b.l15.c30.ctg.1	384	159.5	0	.	p	.	0	S288T	NONSYN	862	864	TCT	96	98	ACT	137;137;136	A;C;T	126;127;129	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2402	porB1b	1035	269	97.77	porB1b.l15.c30.ctg.1	384	159.5	0	.	p	.	0	H290D	NONSYN	868	870	CAT	102	104	GAT	137;134;136	G;A;T	129;129;130	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2402	porB1b	1035	269	97.77	porB1b.l15.c30.ctg.1	384	159.5	0	.	p	.	0	E329D	NONSYN	985	987	GAA	219	221	GAC	229;228;226	G;A;C	215;216;215	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2402	porB1b	1035	269	97.77	porB1b.l15.c30.ctg.1	384	159.5	0	HET	.	.	.	A871G	.	871	871	A	105	105	A	128	A,G	75,48	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2402	porB1b	1035	269	97.77	porB1b.l15.c30.ctg.1	384	159.5	0	HET	.	.	.	G872A	.	872	872	G	106	106	G	129	G,A	75,48	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2402	porB1b	1035	269	97.77	porB1b.l15.c30.ctg.1	384	159.5	0	HET	.	.	.	G877A	.	877	877	G	111	111	G	142	G,A	80,55	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2402	porB1b	1035	269	97.77	porB1b.l15.c30.ctg.1	384	159.5	0	HET	.	.	.	T880C	.	880	880	T	114	114	T	147	T,C	84,54	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2402	porB1b	1035	330	92.69	porB1b.l15.c30.ctg.2	344	79.7	0	.	p	.	0	G189N	NONSYN	565	567	GGC	34	36	AAC	59;60;60	A;A,G;C	25;23,3;26	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2402	porB1b	1035	330	92.69	porB1b.l15.c30.ctg.2	344	79.7	0	.	p	.	0	I209M	NONSYN	625	627	ATC	94	96	ATG	80;81;83	A;T;G,C	76;76;72,2	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2402	porB1b	1035	330	92.69	porB1b.l15.c30.ctg.2	344	79.7	0	.	p	.	0	E210_Y211insR	INS	628	628	G	97	97	G	86	G	76	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2402	porB1b	1035	330	92.69	porB1b.l15.c30.ctg.2	344	79.7	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	103	103	T	85	T	79	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2402	porB1b	1035	323	91.12	porB1b.l15.c30.ctg.3	338	55.6	0	.	p	.	0	G189N	NONSYN	565	567	GGC	30	32	AAC	33;33;35	A;A,G;C	11;0,11;13	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2402	porB1b	1035	323	91.12	porB1b.l15.c30.ctg.3	338	55.6	0	.	p	.	0	I209_E210insGI	INS	625	625	A	90	90	A	52	A	51	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2402	porB1b	1035	323	91.12	porB1b.l15.c30.ctg.3	338	55.6	0	.	p	.	0	E210fs	FSHIFT	628	628	G	99	99	G	60	G	57	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2402	porB1b	1035	323	91.12	porB1b.l15.c30.ctg.3	338	55.6	0	HET	.	.	.	G626C	.	626	626	T	92	92	G	50	G,C	0,48	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2402	porB1b	1035	626	96.96	porB1b.l15.c30.ctg.4	796	146.5	0	.	p	.	0	V75I	NONSYN	223	225	GTT	390	392	ATT	180;180;180	A,G;T;T	96,75;171;171	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2402	porB1b	1035	626	96.96	porB1b.l15.c30.ctg.4	796	146.5	0	.	p	.	0	T89S	NONSYN	265	267	ACC	432	434	AGC	193;186;187	A;G,C;C	180;99,76;177	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2402	porB1b	1035	626	96.96	porB1b.l15.c30.ctg.4	796	146.5	0	.	p	.	0	V98I	NONSYN	292	294	GTC	459	461	ATC	183;184;182	A,G;T;C	105,64;170;171	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2402	porB1b	1035	626	96.96	porB1b.l15.c30.ctg.4	796	146.5	0	.	p	.	0	V109A	NONSYN	325	327	GTC	492	494	GCC	180;181;188	G;C,T;C	157;97,60;174	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2402	porB1b	1035	626	96.96	porB1b.l15.c30.ctg.4	796	146.5	0	.	p	.	0	A121S	NONSYN	361	363	GCC	528	530	AGC	150;147;158	A,G;G,C;C	84,57;84,57;144	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2402	porB1b	1035	626	96.96	porB1b.l15.c30.ctg.4	796	146.5	0	.	p	.	0	N122K	NONSYN	364	366	AAC	531	533	AAA	155;156;155	A;A;A,C	142;144;79,63	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2402	porB1b	1035	626	96.96	porB1b.l15.c30.ctg.4	796	146.5	0	.	p	.	0	F135L	NONSYN	403	405	TTT	570	572	CTT	168;170;172	C;T;T	165;167;168	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2402	porB1b	1035	626	96.96	porB1b.l15.c30.ctg.4	796	146.5	0	.	p	.	0	R143E	NONSYN	427	429	AGA	594	596	GAA	160;156;157	G;A,G;A	153;90,62;150	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2402	porB1b	1035	626	96.96	porB1b.l15.c30.ctg.4	796	146.5	0	.	p	.	0	G189N	NONSYN	565	567	GGC	732	734	AAC	117;113;113	A;A,G;C	106;65,35;101	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	645	2402	porB1b	1035	626	96.96	porB1b.l15.c30.ctg.4	796	146.5	0	HET	.	.	.	A143G	.	143	143	A	310	310	A	167	A,G	95,67	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	155	9676	rpoB	4179	4179	100.0	rpoB.l6.c4.ctg.1	4913	196.3	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2062	2064	AAT	211;215;215	A,C;A;T	119,84;205;204	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	155	9676	rpoB	4179	4179	100.0	rpoB.l6.c4.ctg.1	4913	196.3	0	HET	.	.	.	T3117C	.	3117	3117	T	3522	3522	T	198	T,C	94,96	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	155	9676	rpoB	4179	4179	100.0	rpoB.l6.c4.ctg.1	4913	196.3	0	HET	.	.	.	T3042C	.	3042	3042	T	3447	3447	T	193	T,C	105,76	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	155	9676	rpoB	4179	4179	100.0	rpoB.l6.c4.ctg.1	4913	196.3	0	HET	.	.	.	C2313T	.	2313	2313	C	2718	2718	C	242	C,T	131,102	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	155	1068	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1199	88.8	1	SNP	p	V57M	1	.	.	169	171	ATG	605	607	ATG	205;208;209	A,G;T;G	115,82;197;201	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
